Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France
- PMID: 27651009
- DOI: 10.1684/pnv.2016.0629
Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France
Abstract
Cholinesterase inhibitors and memantine are used from 15 years, in Alzheimer's disease. Benefits have been demonstrated according to cognition, activities of daily living, affective symptoms and behavior, and global impression of change. The aims of this paper are: 1) to describe how these treatments are used in France with a sample survey managed by the national federation of the french CMRR; 2) to study data about efficacy, safety, medicoeconomic impacts and how they are used in Europe.
Keywords: Alzheimer's disease; cholinesterase inhibitors; efficiency; memantine; safety.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical